Stanford University
Showing 16,101-16,150 of 36,179 Results
-
Eric I. Knudsen
Edward C. and Amy H. Sewall Professor in the School of Medicine, Emeritus
Current Research and Scholarly InterestsCellular mechanisms of spatial attention and learning, studied in the central nervous system in birds, using behavioral, systems, cellular and molecular techniques.
-
Donald Knuth
Fletcher Jones Professor of Computer Science, Emeritus
BioDonald Ervin Knuth is an American computer scientist, mathematician, and Professor Emeritus at Stanford University.
He is the author of the multi-volume work The Art of Computer Programming and has been called the "father" of the analysis of algorithms. He contributed to the development of the rigorous analysis of the computational complexity of algorithms and systematized formal mathematical techniques for it. In the process he also popularized the asymptotic notation. In addition to fundamental contributions in several branches of theoretical computer science, Knuth is the creator of the TeX computer typesetting system, the related METAFONT font definition language and rendering system, and the Computer Modern family of typefaces.
As a writer and scholar,[4] Knuth created the WEB and CWEB computer programming systems designed to encourage and facilitate literate programming, and designed the MIX/MMIX instruction set architectures. As a member of the academic and scientific community, Knuth is strongly opposed to the policy of granting software patents. He has expressed his disagreement directly to the patent offices of the United States and Europe. (via Wikipedia) -
Brian Knutson
Professor of Psychology
Current Research and Scholarly InterestsMy lab and I seek to elucidate the neural basis of emotion (affective neuroscience), and explore implications for decision-making (neuroeconomics) and psychopathology (neurophenomics).
-
Justin M Ko, MD, MBA
Clinical Professor, Dermatology
BioDr. Ko joined Stanford Medicine in 2012 and serves as Director and Chief of Medical Dermatology for Stanford Health Care (SHC) while also spearheading the dermatology department's efforts around network development, digital health, quality/safety/performance improvement, and value-based care. He is active in a number of leadership roles within the organization including as an Associate Chief Quality Officer and physician dyadic partner to the Chief Experience Officer, as well as co-chair of the Clinic Advisory Council, a forum of medical and executive leaders of Stanford Health Care’s Ambulatory clinics.
His passion for melanoma, early cancer detection, and improving care delivery drives his efforts and research around leveraging advances in machine learning and artificial intelligence to increase the breadth of populations that can be reached. He developed and runs a digital care delivery program at SHC, providing virtual visits for patients and remote consultations for referring clinicians. He conducts research on and engages in collaborations around interventions that layer advances in machine learning on digital health capabilities to enhance access, quality and value of dermatologic care and is a founder and leader of the Stanford Translational AI in Dermatology (TRAIND) group. He chairs the American Academy of Dermatology's Committee on Augmented Intelligence.
Dr. Ko has also been driven to find new treatments for alopecia areata, an immune-mediated condition that can progress to total hair loss through various clinical trials and translational research efforts. He sits on the clinical research advisory board of the National Alopecia Areata Foundation and is a founder and co-director of the Skin Innovation and Interventional Research Group (SIIRG) which conducts clinical and translational research on skin disease.
He graduated magna cum laude from Harvard University and worked in investment banking; mergers and acquisitions at JP Morgan before going on to earn a combined medical and business degree at Tufts University. During medical school, he was a member of the Alpha Omega Alpha honor society. Dr. Ko then performed his residency at the Harvard Dermatology Residency Training Program where he served as chief resident. -
Yun-Dam Ko
Ph.D. Student in Civil and Environmental Engineering, admitted Autumn 2024
BioYun-Dam Ko's research focuses on combining data-driven solutions with building physics to enhance the sustainability of the urban built environment. His recent work leverages AI to optimize building energy performance, with a specific focus on intelligent HVAC system control and advanced Building Energy Modeling. Bridging research and practice, he previously worked at a startup where he developed and deployed AI solutions to improve building energy efficiency at scale.
-
Blake Koach Gates
Financial Accountant, Facilities & Hospitality Staff Salary Org
Current Role at StanfordFinancial Accountant, Facilities & Hospitality, Stanford GSB
-
Brian Kobilka
Hélène Irwin Fagan Chair of Cardiology
Current Research and Scholarly InterestsStructure, function and physiology of adrenergic receptors.
-
Elif Gediz Kocaoglan
Postdoctoral Scholar, Biology
BioGediz completed her PhD in Bioengineering from Imperial College London. She specialized in plant synthetic biology, developed molecular tools and used regeneration as a model development process to test the functionality of these tools. She is currently a postdoctoral researcher in the Dinneny Lab, where she explores the form-function relationship of the root epidermis and investigates how plants adapt to environmental stress. By integrating biodiversity with synthetic biology approaches, her work aims to uncover design constraints for developing climate-resilient plants.
-
Bruce Koch, Ph.D.
Director of High-Throughput Screening
Current Role at StanfordDirector, ChEM-H/CSB High Throughput Screening Group
Staff Lead, IMA HTS Module
Adviser to the SPARK Program -
Maximilian Koch
Postdoctoral Scholar, Stanford Cancer Institute
Current Research and Scholarly InterestsMy current research focuses on developing novel cellular immunotherapies for pediatric cancers. This includes identifying suitable MHC-restricted and native antigens that are expressed by malignant cells but ideally absent from healthy tissues. On the receptor side, both CARs and TCRs are being characterized for their specificity, affinity, and functionality. Ultimately, non-viral gene delivery methods will be explored and optimized to enable affordable, precise, and consistent cell products.
-
Justin Kochanski
Affiliate, Department Funds
Fellow in Pediatrics - CardiologyBioI'm passionate about delivering high quality, equitable care to patients with congenital heart disease.
-
Mykel Kochenderfer
Associate Professor of Aeronautics and Astronautics, Senior Fellow at the Stanford Institute for Human-Centered AI and Associate Professor, by courtesy, of Computer Science
BioMykel Kochenderfer is Associate Professor of Aeronautics and Astronautics at Stanford University. Prior to joining the faculty, he was at MIT Lincoln Laboratory where he worked on airspace modeling and aircraft collision avoidance, with his early work leading to the establishment of the ACAS X program. He received a Ph.D. from the University of Edinburgh and B.S. and M.S. degrees in computer science from Stanford University. Prof. Kochenderfer is the director of the Stanford Intelligent Systems Laboratory (SISL), conducting research on advanced algorithms and analytical methods for the design of robust decision making systems. Of particular interest are systems for air traffic control, unmanned aircraft, and other aerospace applications where decisions must be made in uncertain, dynamic environments while maintaining safety and efficiency. Research at SISL focuses on efficient computational methods for deriving optimal decision strategies from high-dimensional, probabilistic problem representations. He is an author of "Decision Making under Uncertainty: Theory and Application" (2015), "Algorithms for Optimization" (2019), and "Algorithms for Decision Making" (2022), all from MIT Press. He is a third generation pilot.
-
Bob Kocher
Adjunct Professor, Health Policy
BioBob Kocher, MD is a Partner at Venrock and focuses on healthcare IT and services investments. He currently serves on the Boards of Devoted Health, Virta Health, Aledade, Lyra Health, Sitka, Need, Accompany Health, and Premera Blue Cross. He is a Board Observer at SmithRx, Stride, Suki, and The Public Health Company and previously Included Health (Grand Rounds + Doctor on Demand) and Castlight.
He is an Adjunct Professor at Stanford University School of Medicine and a Non-Resident Senior Fellow and Advisory Board Member at the Leonard D. Schaeffer Center for Health Policy and Economics at USC. He also serves on the Advisory Board of the National Institute of Healthcare Management (NIHCM).
Previously, Bob served in the Obama Administration as Special Assistant to the President for Healthcare and Economic Policy on the National Economic Council, as a Partner at McKinsey & Company, and is an internal medicine doctor. -
Kiran Kocherlakota
Director, Proposal Development Office, SoM Proposal Development Office
Current Role at StanfordDr. Kiran Kocherlakota is dedicated to empowering research faculty members to effectively compete for coveted funding opportunities
-
Gabriele Kockelkoren
Postdoctoral Scholar, Genetics
BioGabriele has a strong background in both physics and molecular biology and, accordingly, he strives in interdisciplinary environments. After completing a cum laude BSc. and MSc. in Nanobiology at the Technical University of Delft in The Netherlands, Gabriele pursued a PhD at the University of Copenhagen under the supervision of Prof. Dimitrios Stamou. In his PhD, Gabriele studied the nanoscale spatial organization of G protein-coupled receptors (GPCRs) at the plasma membrane of living cells. Importantly, his work reveals heterogeneous spatial patterns of receptor density and activation, that are modulated in a drug-dependent manner. These findings identify GPCR spatial organization as an integral element of their activity and signaling. Currently, Gabriele is a Postdoctoral Fellow in the lab of Prof. Alice Ting developing programmable receptors for molecular sensing and controlling cellular behaviour.
-
Lynn Kern Koegel
Clinical Professor, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
BioDr. Lynn Kern Koegel has been active in the development of programs to improve communication in children with autism, including the development of first words, grammatical structures, pragmatics, and social conversation. In addition to her published books and articles in the area of communication and language development, she has developed and published procedures and field manuals in the area of self-management and functional analysis that are used in school districts and by parents throughout the United States, as well as translated in other major languages. Dr. Lynn Koegel is the author of Overcoming Autism and Growing Up on the Spectrum with parent Claire LaZebnik, published by Viking/Penguin and available in most bookstores. Lynn Koegel and her husband, Robert, are the developers of Pivotal Response Treatment which focuses on motivation. The Koegels have been the recipients of many awards, including the first annual Children’s Television Workshop Sesame Street Award for “Brightening the Lives of Children”, the first annual Autism Speaks award for “Science and Research” and the International ABA award for “enduring programmatic contributions in behavior analysis.” In addition, Dr. Lynn Koegel appeared on ABC’s hit show “Supernanny” working with a child with autism. Their work has also been showcased on ABC, CBS, NBC, PBS, and the Discovery Channel. The Koegels are the recipients of many state, federal, and private foundation gifts and grants for developing interventions and helping families with autism spectrum disorder.
-
Robert Koegel
Senior Research Scientist, Psychiatry and Behavioral Sciences - Child & Adolescent Psychiatry and Child Development
Current Role at StanfordSenior Research Scholar. (1) Conducting and publishing research related to the education, understanding, and treatment of autism; (2) Training professionals and family members in Pivotal ResponseTreatment.
